April McClain Delaney
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsApril McClain Delaney bought $1,001 - $15,000 in $LH on October 31, 2025 — 32 days before the Kidd’s Stuttering Act (HR6364) was introduced, which mandates Medicaid and CHIP coverage for childhood-onset fluency disorder screenings.
April McClain Delaney bought $1,001 - $15,000 in $LH on October 31, 2025 — 33 days before the ANCHOR Act of 2025 (HR6408) was introduced, which expands Medicaid eligibility for individuals with serious mental illness or substance use disorder.
April McClain Delaney bought $1,001 - $15,000 in $LH on October 31, 2025 — 39 days before the Ensuring Excellence in Mental Health Act (S3402) was introduced, which expands Medicare and Medicaid coverage for certified community behavioral health clinics.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $NDAQ | Nasdaq, Inc. - Common Stock | $15K-$50K | — | — | — | Oct 22, 2025 |
| BUY | $TECH | Bio-Techne Corp - Common Stock | $1K-$15K | — | — | — | Oct 22, 2025 |
| BUY | $BJ | BJ's Wholesale Club Holdings, Inc. Common Stock | $1K-$15K | $93.00 | — | — | Oct 16, 2025 |
| BUY | $BJ | BJ's Wholesale Club Holdings, Inc. Common Stock | $1K-$15K | $93.00 | — | — | Oct 15, 2025 |
| BUY | $BRO | Brown & Brown, Inc. Common Stock | $1K-$15K | $80.30 | — | — | Oct 29, 2025 |
| BUY | $BRO | Brown & Brown, Inc. Common Stock | $1K-$15K | $80.30 | — | — | Oct 31, 2025 |
| BUY | $LH | Labcorp Holdings Inc. Common Stock | $1K-$15K | — | — | — | Oct 29, 2025 |
| BUY | $LH | Labcorp Holdings Inc. Common Stock | $1K-$15K | — | — | — | Oct 31, 2025 |
| BUY | $NDAQ | Nasdaq, Inc. - Common Stock | $1K-$15K | — | — | — | Oct 9, 2025 |
| BUY | $PAYX | Paychex, Inc. - Common Stock | $1K-$15K | — | — | — | Oct 1, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Kid PROOF Act of 2025
HR6396 (Kid PROOF Act) expands eligible uses of existing SUPPORT Act grants for pediatric suicide and overdose prevention but authorizes no new funding and remains in early committee stage. No measurable revenue impact on any publicly traded company.
Repealing the IMD Exclusion Act
HR 6727 eliminates a 16-bed limit on Medicaid reimbursement for inpatient behavioral health, structurally expanding the addressable market for psychiatric hospitals by an estimated 15–30%. The bill is early-stage (referred to committee), so no price action has materialized in $UHS or $ACAD from this bill specifically. Current data shows $UHS at $168.57 (down 5.81% over 30 days) and $ACAD at $22.47 (up 2.32% over 7 days).
Thyroid Disease CARE Act of 2025
HR6897 (Thyroid Disease CARE Act) authorizes $30M/year for five years for thyroid disease research and improved diagnostics. The bill is in early stage — referred to House Energy and Commerce Committee on December 18, 2025. Real market data shows diagnostic stocks trending negative over the past 30 days, with Labcorp down 1.53% and Abbott down 11.85%. Any impact is procedural and speculative at this stage.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025
HR 6894 is an early-stage, low-probability bill that expands Medicare cardiac and pulmonary rehab supervision to PAs, NPs, and CNSs. It authorizes zero funding and remains in committee. Marginal upside for healthcare staffing firm AMN (allied health demand) is possible but contingent on passage. Labcorp (LH) sees no structural impact. Current market prices: AMN $20.62, LH $262.99.
Kidd’s Stuttering Act
HR6364 (Kidd's Stuttering Act) mandates Medicaid and CHIP coverage for childhood stuttering screening and speech therapy, creating a new, guaranteed revenue stream for managed care organizations and speech therapy providers. The bill is in early stage (referred to committee) with 12 cosponsors. Real market data shows UNH, ELV, and HUM all up 32-46% in the last 30 days, though this is likely driven by broader sector momentum rather than this specific bill at this stage.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
HR3383 — the Increasing Investor Opportunities Act — removes SEC restrictions on closed-end fund investments in private funds, directly benefiting private equity managers $BX and $KKR through expanded AUM channels, and exchange operators $CBOE, $ICE, and $NDAQ through increased listing and trading volume. The bill passed committee 41-10 and was considered under rule in December 2025; over the last 30 days, $BX gained +8.31% and $KKR +12.42%, consistent with growing passage expectations.
BRAVE Act of 2025
The BRAVE Act of 2025 is an early-stage authorization bill expanding VA mental health services with zero new funding. It has no direct revenue impact on private hospital operators HCA and UHS. Both stocks have declined sharply over the past 30 days driven by broader healthcare sector headwinds, not this procedural legislation.
Employee Profit-Sharing Encouragement Act of 2025
HR6418 is a single-sponsor bill in early legislative stage (referred to Ways and Means). No hearings, no companion bill, no CBO score. The structural link to payroll software providers is indirect and contingent on future legislative action. Market impact is negligible near-term.
ANCHOR Act of 2025
The ANCHOR Act of 2025 creates a state option to expand Medicaid to uninsured adults with serious mental illness or substance use disorder at or below 100% FPL. The bill is early-stage (referred to House Energy & Commerce) but has a Senate companion and regulatory tailwinds from an April 2026 executive order. Pure-play Medicaid managed care insurers Centene ($CNC) and Molina ($MOH) are structural beneficiaries, though no funding is authorized until states adopt and federal appropriations follow.
Ensuring Excellence in Mental Health Act
The Ensuring Excellence in Mental Health Act expands Medicare and Medicaid coverage for Certified Community Behavioral Health Clinics (CCBHCs), creating a new revenue stream for managed care organizations via established prospective payment systems. The bill is in early committee stage with three cosponsors and bipartisan support, but actual appropriations are separate. Real market data shows UNH, CNC, and MOH have seen massive recent rallies — CNC up 28% in 7 days and 63.5% in 30 days, MOH up 10.89% in 7 days, UNH up 36.12% in 30 days — indicating the market is already pricing in tailwinds from this and related behavioral health policy moves.
Other Filings by April McClain Delaney
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.